JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 28, 2004; DOI: 10.1124/jpet.104.069286


0022-3565/04/3112-668-676$20.00
JPET 311:668-676, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.069286v1
jpet.104.069286v2
311/2/668    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menor, C.
Right arrow Articles by Guijarro, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menor, C.
Right arrow Articles by Guijarro, L. G.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Azathioprine Acts upon Rat Hepatocyte Mitochondria and Stress-Activated Protein Kinases Leading to Necrosis: Protective Role of N-Acetyl-L-cysteine

César Menor, María D. Fernández-Moreno, Jesús A. Fueyo, Oscar Escribano, Tomás Olleros, Encarna Arriaza, Carlos Cara, Michele Lorusso, Marco Di Paola, Irene D. Román, and Luis G. Guijarro

Unidad de Toxicología Molecular Hepática, Departamento de Bioquímica y Biología Molecular, Universidad de Alcalá, Alcalá de Henares, Spain (C.M., M.D.F.-M., J.A.F., O.E., I.D.R., L.G.G.); Farmasierra S.A., Madrid, Spain (T.O., E.A.); Celltech Pharma S.A., Madrid, Spain (C.C.); and Institute of Medical Biochemistry and Chemistry, University of Bari, Bari, Italy (M.L., M.D.P.)

Azathioprine is an immunosuppressant drug widely used. Our purpose was to 1) determine whether its associated hepatotoxicity could be attributable to the induction of a necrotic or apoptotic effect in hepatocytes, and 2) elucidate the mechanism involved. To evaluate cellular responses to azathioprine, we used primary culture of isolated rat hepatocytes. Cell metabolic activity, reduced glutathione, cell proliferation, and lactate dehydrogenase release were assessed. Mitochondria were isolated from rat livers, and swelling and oxygen consumption were measured. Mitogen-activated protein kinase pathways and proteins implicated in cell death were analyzed. Azathioprine decreased the viability of hepatocytes and induced the following events: intracellular reduced glutathione (GSH) depletion, metabolic activity reduction, and lactate dehydrogenase release. However, the cell death was not accompanied by DNA laddering, procaspase-3 cleavage, and cytochrome c release. The negative effects of azathioprine on the viability of hepatocytes were prevented by cotreatment with N-acetyl-L-cysteine. In contrast, 6-mercaptopurine showed no effects on GSH content and metabolic activity. Azathioprine effect on hepatocytes was associated with swelling and increased oxygen consumption of intact isolated rat liver mitochondria. Both effects were cyclosporine A-sensitive, suggesting an involvement of the mitochondrial permeability transition pore in the response to azathioprine. In addition, the drug's effects on hepatocyte viability were partially abrogated by c-Jun N-terminal kinase and p38 kinase inhibitors. In conclusion, our findings suggest that azathioprine effects correlate to mitochondrial dysfunction and activation of stress-activated protein kinase pathways leading to necrotic cell death. These negative effects of the drug could be prevented by coincubation with N-acetyl-L-cysteine.


Received April 1, 2004; accepted June 8, 2004.

Address correspondence to: Dr. Luis G. Guijarro, Unidad de Toxicología Molecular, Departamento de Bioquímica y Biología Molecular, Universidad de Alcalá, E-28871 Alcalá de Henares, Spain. E-mail: luis.gonzalez{at}uah.es




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Morissette, E. Moreau, R. C.-Gaudreault, and F. Marceau
N-Substituted 4-Aminobenzamides (Procainamide Analogs): An Assessment of Multiple Cellular Effects Concerning Ion Trapping
Mol. Pharmacol., December 1, 2005; 68(6): 1576 - 1589.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, H. M. Jansen, W. MacNee, M. Thomeer, B. Wallaert, F. Laurent, et al.
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis.
N. Engl. J. Med., November 24, 2005; 353(21): 2229 - 2242.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. W. Hunninghake
Antioxidant Therapy for Idiopathic Pulmonary Fibrosis.
N. Engl. J. Med., November 24, 2005; 353(21): 2285 - 2287.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.